A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
Molecular Therapy2013Vol. 21(3), pp. 526–532
Citations Over TimeTop 10% of 2013 papers
Tomoko Takai, Katsumi Higaki, Matilde Aguilar‐Moncayo, Teresa Mena‐Barragán, Yuki Hirano, Kei Yura, Liang Yu, Haruaki Ninomiya, M. Isabel García‐Moreno, Yasubumi Sakakibara, Kousaku Ohno, Eiji Nanba, Carmen Ortiz Mellet, José M. Garcı́a Fernández, Yoshiyuki Suzuki
Related Papers
- → Animal models of GM2 gangliosidosis: utility and limitations(2016)43 cited
- → The Novel Symbiotic Phenotype of Enhanced-Nodulating Mutant of Lotus japonicus: astray Mutant is an Early Nodulating Mutant with Wider Nodulation Zone(2002)60 cited
- → Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB G ene(2017)8 cited
- → A new set of adsorption mutants of bacteriophage T4D: Identification of a new gene(1974)29 cited
- → Studies on a Temperature-sensitive Irreparable Mutant of <i>Neurospora Crassa</i>(1960)11 cited